Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Loser

The drugs industry closed the day up 1.9%. Cormedix Inc ( CRMD), Uluru Inc ( ULU), CEL-SCI Corporation ( CVM), and Palatin Technologies Inc ( PTN) were all decliners today within the drugs industry with Vertex Pharmaceuticals ( VRTX) being today's featured drugs loser. Vertex Pharmaceuticals fell $2.64 (-6.5%) to $43.13 on heavy volume. Throughout the day, 3.4 million shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 2.1 million shares.

Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Vertex Pharmaceuticals has a market cap of $9.3 billion and is part of the health care sector. Shares are up 15.6% year to date as of the close of trading on Monday.

TheStreet Ratings rates Vertex as a sell. The company's weaknesses can be seen in multiple areas, such as its generally weak debt management and disappointing return on equity.

On the positive front, Transcept Pharmaceuticals Inc ( TSPT), Tranzyme Inc ( TZYM), Siga Technologies Inc ( SIGA), and Somaxon Pharmaceuticals Inc ( SOMX) were all gainers within the drugs industry with Pfizer Inc ( PFE) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens